← All news

TürkiyeResearch and clinical trials

16 people with retinitis pigmentosa in Erzincan describe delayed diagnosis and struggles with access and bureaucracy

Peer-reviewed publication

A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.

In Erzincan, face-to-face interviews were held with adults with retinitis pigmentosa. The study included 16 people. Participants described how their symptoms were not taken seriously for a long time. They said the path to diagnosis was delayed. Physical barriers, official paperwork and costs made daily life difficult.

What does it mean for patients and families?

Vision loss affects not only the eyes but also work and social life. Ask your doctor about vision rehabilitation and psychological support. This is a small, qualitative study.

Source

PubMed (Healthcare): Living with Retinitis Pigmentosa in Türkiye: Diagnosis, Independence, and Access to Care.

Scientific paper: Living with Retinitis Pigmentosa in Türkiye: Diagnosis, Independence, and Access to Care. Healthcare, 2026. DOI: 10.3390/healthcare14050593 · PubMed 41827546

The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).

This page is translated from the Turkish original.

This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.